Genomic based tumor analysis for gynecologic malignancies is no longer a “nice to have” but it is essential to understanding the unique needs of gynecologic cancer patients. Every gynecologic cancer patient’s tumor is unique and requires a personalized approach to assessment and treatment.

iLife Discoveries is committed to helping inform women about the latest discoveries in gynecologic cancer research and to raise awareness for critical molecular-based cancer tests to help improve patient survival and enhance their quality of life.

iLife Discoveries has a unique and innovative collection of gene-based profiles designed to predict recurrence and drug response for gynecologic cancers. This personalised approach provides gynecologic oncologists with the predictive and prognostic tools they need to confidently treat their patients.

Breast Cancer

Cervical Cancer

Endometrial Cancer

Ovarian Cancer